First Trust Nasdaq Pharmaceuticals ETF Rating $41.20 +0.77 (+1.90%) As of 11:17 AM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort Interest First Trust Nasdaq Pharmaceuticals ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.FTXH Aggregate RatingModerate Buy 2.63Holdings in FTXH have an aggregate rating of Moderate Buy based on 564 analyst ratings issued in the past year covering 25 companies (87.6% of the portfolio).FTXH Aggregate Price Target$41.280.18% UpsideHigh Prediction$41.28Average Prediction$41.28Low Prediction$41.28Holdings in FTXH have an aggregate price target of $41.28 and a range of $41.28 to $41.28 covering 25 companies (87.6% of the portfolio).FTXH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy17 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by First Trust Nasdaq Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 FTXH Holdings ExportWeight In ETFCompanyShare PriceConsensus RatingConsensus Price TargetPossible UpsideNumber of RatingsMarketRank™Indicator(s)ViewRatings7.79%ABBVAbbVie$283.71+3.4%Moderate Buy$277.18 -2.3%304.0001 of 5 starsTrending NewsAnalyst ForecastAnalyst Revision7.41%LLYEli Lilly and Company$1,212.99+4.0%Moderate Buy$1,313.43 8.3%294.851 of 5 starsTrending NewsAnalyst ForecastAnalyst Revision7.16%PFEPfizer$29.16+2.8%Hold$28.72 -1.5%212.9106 of 5 starsTrending NewsAnalyst ForecastAnalyst Revision7.07%JNJJohnson & Johnson$252.16+1.4%Moderate Buy$273.30 8.4%254.4879 of 5 starsTrending NewsEarnings ReportDividend AnnouncementAnalyst ForecastAnalyst Revision7.06%MRKMerck & Co., Inc.$145.67+2.6%Moderate Buy$151.92 4.3%274.5203 of 5 starsTrending NewsAnalyst ForecastAnalyst Revision3.87%VTRSViatris$17.59+1.9%Moderate Buy$20.50 16.6%93.3811 of 5 stars3.69%BIIBBiogen$230.38+0.6%Moderate Buy$236.04 2.5%322.6114 of 5 starsAnalyst Upgrade3.68%GILDGilead Sciences$151.39+2.3%Moderate Buy$159.33 5.2%293.485 of 5 starsAnalyst ForecastAnalyst Revision3.47%AMGNAmgen$425.76+3.1%Hold$387.93 -8.9%303.6194 of 5 starsAnalyst ForecastAnalyst Revision3.47%ZTSZoetis$74.99+0.9%Hold$101.08 34.8%194.5219 of 5 starsDividend Announcement3.40%UTHRUnited Therapeutics$540.89-0.5%Moderate Buy$639.08 18.2%144.092 of 5 starsTrending NewsAnalyst ForecastInsider Trade3.39%VRTXVertex Pharmaceuticals$494.09+1.8%Moderate Buy$579.81 17.4%284.0074 of 5 stars3.39%REGNRegeneron Pharmaceuticals$765.89+1.7%Moderate Buy$834.24 8.9%314.5929 of 5 starsPositive News3.32%INCYIncyte$110.99+2.2%Moderate Buy$128.20 15.5%253.9701 of 5 starsAnalyst ForecastGap Up3.27%BMYBristol Myers Squibb$57.78+2.0%Hold$64.88 12.3%304.6689 of 5 starsTrending NewsAnalyst Forecast2.59%JAZZJazz Pharmaceuticals$215.18+2.3%Buy$291.25 35.4%204.2429 of 5 stars2.41%EXELExelixis$60.80+2.2%Hold$50.79 -16.5%202.3427 of 5 starsAnalyst Revision2.24%ILMNIllumina$269.85-0.5%Hold$225.94 -16.3%182.9484 of 5 starsAnalyst Upgrade1.62%HALOHalozyme Therapeutics$117.98+7.6%Moderate Buy$96.50 -18.2%123.2944 of 5 starsAnalyst Forecast1.52%MEDPMedpace$616.52+1.1%Hold$607.73 -1.4%132.6766 of 5 starsUpcoming Earnings1.22%NBIXNeurocrine Biosciences$136.09+0.7%Moderate Buy$201.14 47.8%244.8341 of 5 starsAnalyst Forecast1.18%ALNYAlnylam Pharmaceuticals$224.89+0.5%Moderate Buy$366.50 63.0%254.1883 of 5 stars1.18%BMRNBioMarin Pharmaceutical$55.02+1.2%Moderate Buy$88.87 61.5%244.245 of 5 starsAnalyst Upgrade1.18%ELANElanco Animal Health$22.61+0.9%Moderate Buy$29.70 31.4%123.8091 of 5 stars1.06%CRLCharles River Laboratories International$303.26+1.4%Moderate Buy$302.33 -0.3%172.0444 of 5 starsAnalyst Forecast This page (NASDAQ:FTXH) was last updated on 10/14/2026 by MarketBeat.com Staff. From Our PartnersElon Musk’s One Stock Retirement PlanJeff Brown picked Nvidia in 2016, before it surged 37,000 percent. Now he's tracking a small AI company he say...Brownstone Research | SponsoredTrump's about to unleash his Midterm WeaponTrump is turning the midterms into a referendum on American energy, pushing for more oil, more gas, and lower ...Monument Traders Alliance | SponsoredWall Street legend reveals his top AI stock before Oct. 20Marc Chaikin, the 60-year Wall Street veteran behind the Power Gauge rating system, has flagged a new AI stock...Chaikin Analytics | SponsoredThe Iran War Isn’t Chaos. It’s Strategy.Two thousand missiles struck Iran. Three days later, Dylan Jovine sat in two private meetings with U.S. Congre...Behind the Markets | SponsoredHow one AI fund pays investors every ThursdayOne small fund tied to artificial intelligence stocks delivered $1,051 in a single month, not through selling ...Investors Alley | SponsoredINSANE DRONE FOOTAGENew drone footage shows a mysterious factory rising at one of Elon Musk's most secure facilities, cleared and ...Paradigm Press | SponsoredA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust Nasdaq Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share First Trust Nasdaq Pharmaceuticals ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FTXH Stock Alerts